Protease inhibitors and risk of developing HIV-related sensory neuropathy.
Charlene
C
Crabb
D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D012678:Sensation Disorders / Q000139:chemically induced*
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors